Logo image of AREB

AMERICAN REBEL HOLDINGS INC (AREB) Stock Fundamental Analysis

NASDAQ:AREB - Nasdaq - US02919L5057 - Common Stock - Currency: USD

0.87  -0.04 (-4.4%)

After market: 0.8799 +0.01 (+1.14%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to AREB. AREB was compared to 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of AREB have multiple concerns. AREB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AREB had negative earnings in the past year.
In the past year AREB has reported a negative cash flow from operations.
AREB had negative earnings in each of the past 5 years.
AREB had a negative operating cash flow in each of the past 5 years.
AREB Yearly Net Income VS EBIT VS OCF VS FCFAREB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -128.15%, AREB is not doing good in the industry: 98.78% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -669.48%, AREB is doing worse than 92.68% of the companies in the same industry.
Industry RankSector Rank
ROA -128.15%
ROE -669.48%
ROIC N/A
ROA(3y)-252.09%
ROA(5y)-339.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AREB Yearly ROA, ROE, ROICAREB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2K 4K 6K

1.3 Margins

AREB has a Gross Margin of 2.45%. This is amonst the worse of the industry: AREB underperforms 90.24% of its industry peers.
In the last couple of years the Gross Margin of AREB has declined.
The Profit Margin and Operating Margin are not available for AREB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.12%
GM growth 5Y-28.82%
AREB Yearly Profit, Operating, Gross MarginsAREB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K -5K

More info and screens

0

2. Health

2.1 Basic Checks

AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AREB has been reduced compared to 1 year ago.
The number of shares outstanding for AREB has been increased compared to 5 years ago.
AREB has a worse debt/assets ratio than last year.
AREB Yearly Shares OutstandingAREB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K
AREB Yearly Total Debt VS Total AssetsAREB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

AREB has an Altman-Z score of -7.75. This is a bad value and indicates that AREB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.75, AREB is doing worse than 91.46% of the companies in the same industry.
A Debt/Equity ratio of 2.57 is on the high side and indicates that AREB has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.57, AREB is doing worse than 85.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Altman-Z -7.75
ROIC/WACCN/A
WACC13.25%
AREB Yearly LT Debt VS Equity VS FCFAREB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.93 indicates that AREB may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, AREB is doing worse than 79.27% of the companies in the same industry.
AREB has a Quick Ratio of 0.93. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
AREB has a worse Quick ratio (0.28) than 96.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.28
AREB Yearly Current Assets VS Current LiabilitesAREB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

AREB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.84%.
Looking at the last year, AREB shows a decrease in Revenue. The Revenue has decreased by -4.96% in the last year.
The Revenue has been growing by 161.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-824.19%
Revenue 1Y (TTM)-4.96%
Revenue growth 3Y133.29%
Revenue growth 5Y161.83%
Sales Q2Q%-11.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREB Yearly Revenue VS EstimatesAREB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AREB Yearly EPS VS EstimatesAREB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AREB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 7.75, the valuation of AREB can be described as very cheap.
Based on the Price/Forward Earnings ratio, AREB is valued cheaper than 95.12% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. AREB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.75
AREB Price Earnings VS Forward Price EarningsAREB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AREB Per share dataAREB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

AREB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AREB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN REBEL HOLDINGS INC

NASDAQ:AREB (2/21/2025, 8:01:37 PM)

After market: 0.8799 +0.01 (+1.14%)

0.87

-0.04 (-4.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-21 2024-11-21
Earnings (Next)04-10 2025-04-10/amc
Inst Owners2.08%
Inst Owner Change-98.56%
Ins Owners0.17%
Ins Owner Change0%
Market Cap2.14M
Analysts82.86
Price TargetN/A
Short Float %1.77%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.75
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 4.12
EV/EBITDA N/A
EPS(TTM)-19.44
EYN/A
EPS(NY)0.11
Fwd EY12.9%
FCF(TTM)-3.36
FCFYN/A
OCF(TTM)-3.36
OCFYN/A
SpS6.19
BVpS1.02
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -128.15%
ROE -669.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.45%
FCFM N/A
ROA(3y)-252.09%
ROA(5y)-339.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.12%
GM growth 5Y-28.82%
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.28
Altman-Z -7.75
F-Score3
WACC13.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-824.19%
EPS Next Y266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.96%
Revenue growth 3Y133.29%
Revenue growth 5Y161.83%
Sales Q2Q%-11.3%
Revenue Next Year21.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-208.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-89.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.41%
OCF growth 3YN/A
OCF growth 5YN/A